Cargando…
Osteoblastic glucocorticoid signaling exacerbates high-fat-diet- induced bone loss and obesity
Chronic high-fat diet (HFD) consumption not only promotes obesity and insulin resistance, but also causes bone loss through mechanisms that are not well understood. Here, we fed wild-type CD-1 mice either chow or a HFD (43% of energy from fat) for 18 weeks; HFD-fed mice exhibited decreased trabecula...
Autores principales: | Kim, Sarah, Henneicke, Holger, Cavanagh, Lauryn L., Macfarlane, Eugenie, Thai, Lee Joanne, Foong, Daphne, Gasparini, Sylvia J., Fong-Yee, Colette, Swarbrick, Michael M., Seibel, Markus J., Zhou, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408138/ https://www.ncbi.nlm.nih.gov/pubmed/34465731 http://dx.doi.org/10.1038/s41413-021-00159-9 |
Ejemplares similares
-
Skeletal glucocorticoid signalling determines leptin resistance and obesity in aging mice
por: Henneicke, Holger, et al.
Publicado: (2020) -
Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes
por: Gado, Manuel, et al.
Publicado: (2022) -
Arthritis and the role of endogenous glucocorticoids
por: Macfarlane, Eugenie, et al.
Publicado: (2020) -
The Role of Glucocorticoids in the Management of COVID-19
por: Alexaki, Vasileia Ismini, et al.
Publicado: (2021) -
Acute murine antigen-induced arthritis is not affected by disruption of osteoblastic glucocorticoid signalling
por: Spies, Cornelia M, et al.
Publicado: (2014)